QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateInd...

 patterson-cos-q3-2025-adj-eps-043-misses-062-estimate-sales-157b-miss-164b-estimate

Patterson Cos (NASDAQ:PDCO) reported quarterly earnings of $0.43 per share which missed the analyst consensus estimate of $0.62...

 morgan-stanley-maintains-equal-weight-on-patterson-cos-raises-price-target-to-3135

Morgan Stanley analyst Erin Wright maintains Patterson Cos (NASDAQ:PDCO) with a Equal-Weight and raises the price target fro...

 walgreens-boots-alliance-alaska-air-and-rh-are-among-top-mid-cap-gainers-last-week-december-9-13-are-the-others-in-your-portfolio

These 10 mid-cap stocks performed well last week. Are they in your portfolio? PDCO, NAMS, WBA, NVCR, RH, PTVE, CRK, RNW, ALK, S...

 what-does-dental-player-pattersons-41-billion-deal-mean-for-other-players

Patient Square Capital agrees to buy Patterson Companies for $4.1 billion. Analysts predict minimal regulatory hurdles and a st...

 baird-maintains-neutral-on-patterson-cos-raises-price-target-to-31

Baird analyst Jeff Johnson maintains Patterson Cos (NASDAQ:PDCO) with a Neutral and raises the price target from $25 to $31.

 leerink-partners-downgrades-patterson-cos-to-market-perform-raises-price-target-to-3135

Leerink Partners analyst Michael Cherny downgrades Patterson Cos (NASDAQ:PDCO) from Outperform to Market Perform and raises ...

 dental-product-supplier-patterson-companies-goes-private-in-41-billion-deal

Patient Square Capital to acquire Patterson Companies for $4.1B. The deal is set to close in fiscal Q4 2025, taking the company...

 piper-sandler-maintains-neutral-on-patterson-cos-lowers-price-target-to-24

Piper Sandler analyst Jason Bednar maintains Patterson Cos (NASDAQ:PDCO) with a Neutral and lowers the price target from $26...

 baird-maintains-neutral-on-patterson-cos-lowers-price-target-to-25

Baird analyst Jeff Johnson maintains Patterson Cos (NASDAQ:PDCO) with a Neutral and lowers the price target from $28 to $25.

 stifel-maintains-hold-on-patterson-cos-lowers-price-target-to-24

Stifel analyst Jonathan Block maintains Patterson Cos (NASDAQ:PDCO) with a Hold and lowers the price target from $25 to $24.

 dental-supplier-patterson-companies-is-up-for-sale-after-posting-mixed-q2-earnings

Patterson Companies Q2 2025 results showed $1.67 billion in sales, a 1.3% increase, with updated EPS guidance and mixed perform...

 patterson-companies-expects-2025-adjusted-eps-of-225-235-vs-consensus-of-232-and-prior-guidance-of-233-243

Fiscal 2025 GuidancePatterson Companies today revised its fiscal 2025 earnings guidance, which is provided on both a GAAP and n...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION